Patricia Camporro Burguillo

Mrs. Patricia Camporro Burguillo


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
RVRicardo José Vaamonde-Martín
Ricardo José Vaamonde-Martín
MBMónica Ballesta-Ruiz
Mónica Ballesta-Ruiz
AGANTONIA SÁNCHEZ GIL
ANTONIA SÁNCHEZ GIL
ACAna M. Corbalán-Fernández
Ana M. Corbalán-Fernández
GAGemma Alonso-Sánchez
Gemma Alonso-Sánchez
MCMaría-Dolores Chirlaque-López
María-Dolores Chirlaque-López
Background: Testicular cancer (TC) incidence has risen globally, yet population-based net survival and flexible parametric modeling across histological subtypes in Spain remain insufficiently characterized. Methods: Incident TC cases (1993–2017) were obtained from the Spanish Network of Cancer Registries (REDECAN). Age-standardized incidence rates (ASIR, 2013 European standard) and temporal trends (Joinpoint regression APC) were analyzed by age and histology, including seminomatous germ cell tumors (SGCTs), nonseminomatous germ cell tumors (NSGCTs), and others. Five-year overall survival (OS, Kaplan-Meier) and net survival (NS, Pohar-Perme, ICSS-3 standardized) for 2000–2017 were evaluated. Multivariable flexible parametric models estimated excess hazard ratio (EHR) of mortality. Results: A total of 5,582 cases were analyzed. ASIR increased from 2.31 per 100,000 in 1993–2000 to 5.08 in 2010–2017 (APC=4.6, 95%CI: 4.1; 5.3). Five-year OS and NS reached 94.3% and 95.9% in 2009–2017, respectively. SGCTs demonstrated superior 5-year NS (97.1%) compared to NSGCTs (91.6%) and others (87.8%). Multivariable flexible models revealed significantly higher excess mortality for age ≥40 years (EHR=3.28, 95%CI: 1.95; 5.52 vs 15–24 years), NSGCTs (EHR=4.20, 95%CI: 2.79; 6.30 vs SGCTs), and 'Others' (EHR=5.77), while survival improved in 2009–2017 (EHR=0.70, 95%CI: 0.51; 0.96). Conclusions: TC incidence in Spain more than doubled over 25 years. Survival is generally excellent but exhibits marked disparities by histology and age, emphasizing the need for age-tailored clinical management.